Adagio Medical to Present at BTIG 13th Annual MedTech Conference
ByAinvest
Monday, Feb 2, 2026 8:14 am ET1min read
ADGM--
Adagio Medical Holdings, Inc. announced participation at the BTIG 13th Annual MedTech conference on February 10, 2026. The company is focused on developing catheter ablation technologies for cardiac arrhythmias using its ULTA ablation technology. Adagio is currently evaluating its vCLAS Cryoablation System in the FULCRUM-VT U.S. Pivotal IDE Trial. The system is commercially available in Europe but limited to investigational use in the US.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet